And now the feds are taking over the distribution of monocloncal antibodies

By Meryl Nass, MD | September 16, 2021 From the WaPo we learn there is a shortage of monoclonal antibodies, so the feds will take over distribution.  Hmm. We don’t know anything about long-term side effects of monoclonals. Monoclonal antibodies are an effective and very expensive product if used in the first week of illness–just like […]

Source